Compare Cytokinetics Inc (CYTK) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Kinder Morgan Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Kinder Morgan Inc trades at $31.59 (market cap $70.10B). The key difference: Kinder Morgan Inc is far larger — about 6.6× Cytokinetics Inc's market cap, and Kinder Morgan Inc pays a 3.75% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | KMI | |
|---|---|---|
Market Cap | $10.63B | $70.10B |
Sector | Technology | Energy |
52-Week High | $87.26 | $34.31 |
52-Week Low | $34.31 | $25.84 |
Enterprise Value | $10.74B | $102.15B |
Dividend Yield | — | 3.75% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
